Leilei Jiang

High-dose hyperfractionated simultaneous integrated boost radiotherapy versus standard-dose radiotherapy for limited-stage small-cell lung cancer in China: a multicentre, open-label, randomised, phase 3 trial

Jiayi Yu, Leilei Jiang, Lina Zhao et al. · The Lancet Respiratory Medicine · 2024 · 37 citations

Medicine, Oncology, Radiation Oncology +16

First-line atezolizumab/durvalumab plus platinum–etoposide combined with radiotherapy in extensive-stage small-cell lung cancer

Lijuan Li, Dan Yang, Yanmei Min et al. · BMC Cancer · 2023 · 30 citations · Full text

Medicine, Oncology, Radiation Oncology +10

Induction immunochemotherapy followed by radiotherapy for patients with unresectable locally advanced or metastatic esophageal cancer: A propensity score-matched analysis

Wei Deng, Xiao Chang, Xin Dong et al. · International Immunopharmacology · 2023 · 17 citations

Medicine, Oncology, Radiation Oncology +15

Stereotactic ablative radiotherapy of 60 Gy in eight fractions is safe for ultracentral non‐small cell lung cancer

Dan Yang, Jianing Cui, Jun Zhao et al. · Thoracic Cancer · 2020 · 16 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Prediction of Clinical Outcome in Locally Advanced Non-Small Cell Lung Cancer Patients Treated With Chemoradiotherapy by Plasma Markers

Xin Sui, Leilei Jiang, Huajing Teng et al. · Frontiers in Oncology · 2021 · 13 citations · Full text

Medicine, Immunology, Oncology +17